LignaMed Overview
Founded
2013
Status
Private
Latest Deal Type
Accelerator/Inc
Investors
3
LignaMed General Information
Description
Developer of molecule therapy for the treatment for cancer. The company develops therapeutics from flaxseed derivatives to amplify effects of chemotherapy and radiation treatment on cancer cells.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
- Philadelphia, PA
- United States
LignaMed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 10-Mar-2015 | Completed | Startup | |||
| 2. Accelerator/Incubator | 04-Mar-2015 | Completed | Startup | |||
| 1. Grant | 18-Jan-2014 | $825K | Completed | Startup |
LignaMed Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thais Sielecki | Chief Scientific Officer | ||
| Melpo Christofidou Solomidou Ph.D | Founder & Chairman of Scientific Advisory Board | ||
| Jim Harris | Chief Executive Officer |
LignaMed Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dora Mitchell Ph.D | UPstart | Board Member | 000 0000 |
| Melpo Christofidou Solomidou Ph.D | LignaMed | Founder & Chairman of Scientific Advisory Board | 000 0000 |
LignaMed Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| UPstart | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Science Center | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| National Institutes of Health | Government | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial